Clinical Trials & Research

Aug 21 2019 World Plant Milk Day will return on August 22 for its third – and biggest outing. The annual day, a collaboration between global food awareness organization ProVeg International and vegan news service Plant Based News, celebrates the wide array of plant-based alternatives to dairy products and highlights their many benefits – for
0 Comments
A team of researchers from Osaka University, in cooperation with the Institute for Clinical Research and medical institutes participating in the Kansai Molecular Diagnosis Network for CNS Tumors (KNBTG), conducted the largest-ever retrospective cohort study for Japanese patients with glioblastoma (GBM), proposing an underlying prognosis biomarker responsible for the survival difference between two cohorts: an
0 Comments
Californians voted in 2004 to shell out billions of dollars in taxpayer money to fund cutting-edge stem cell treatments. Proposition 71 could lead to cures for cancer, Alzheimer’s and other devastating diseases, voters were told. Actor Michael J. Fox, who has Parkinson’s disease, said in one campaign ad that the measure “could save the life
0 Comments
Attention deficit/hyperactivity disorder (ADHD) affects an increasing number of people worldwide, with an estimated 6.1 million children were living with ADHD in 2016, according to the National Survey of Children’s Health. Now, MRI scans have revealed that children taking the common medication methylphenidate experience alterations in the distribution of white matter in the brain. This
0 Comments
The U.S. Food and Drug Administration today approved Pretomanid Tablets in combination with bedaquiline and linezolid for the treatment of a specific type of highly treatment-resistant tuberculosis (TB) of the lungs. The threat of antimicrobial-resistant infections is a key challenge we face as a public health agency. The bacterium that causes tuberculosis can develop resistance
0 Comments
For his pioneering hematology research, University of Chicago Medicine oncologist and professor Richard A. Larson, MD, will receive the 2019 Henry M. Stratton Medal from the American Society of Hematology. The medal, one of the cancer field’s top honors, recognizes investigators who have made well-recognized contributions to hematology research over the past several years. I
0 Comments
Targeted drug-delivery systems hold significant promise for treating cancer effectively by sparing healthy surrounding tissues. But the promising approach can only work if the drug hits its target. A Northwestern University research team has developed a new way to determine whether or not single drug-delivery nanoparticles will successfully hit their intended targets — by simply
0 Comments
Research by the University of Greenwich examines the relationship between the use of recycling and waste management systems and absence rates among Local Authority waste collection workers due to Musculoskeletal Disorders (MSDs). The study shows that the use of wheeled bins is linked to lower sickness absence rates. It suggests that absence rates among 60,000
0 Comments
Scientists at Trinity College Dublin have announced a major breakthrough with important implications for sufferers of a common eye disease – dry Age-Related Macular Degeneration (AMD) – which can cause total blindness in sufferers, and for which there are currently no approved therapies. The scientists discovered that a key component of the cells lining the
0 Comments
A new study, published in Annals of Internal Medicine, highlights the need for increased awareness of mental health disorders among adults with cerebral palsy. According to the Centers for Disease Control and Prevention, 1 in every 323 children in the United States has been identified as having cerebral palsy.” Daniel Whitney, Ph.D., assistant professor of
0 Comments
Between 50 to 70 million Americans have a sleep disorder. Sleepless nights are associated with a number of adverse health outcomes including heart disease, high blood pressure, diabetes, and certain cancers. Evening use of alcohol, caffeine and nicotine are believed to sabotage sleep. Yet, studies examining their effects on sleep are limited by small sample
0 Comments
Dr. Michelle Lofwall, professor of behavioral science and psychiatry in the University of Kentucky College of Medicine, is one of three national addiction physician experts who led a team of healthcare professionals in developing a new core curriculum designed to educate primary care providers on the prevention, assessment and treatment of substance use disorders (SUD)
0 Comments
The discovery that an essential protein plays a protective role during cell division, could open the door to better targeted treatment of fast-growing cancer cells. Polo-like kinase (PLK1) was previously thought to have a major function – helping chromosome alignment during mitosis for cell division. But scientists at the Genome Damage and Stability Centre (GDSC)
0 Comments
A new clinical trial tests the benefits of an oral drug for people with nonalcoholic fatty liver disease and yields very promising results. Scientists may now have a medication for nonalcoholic fatty liver disease. In the United States, 30–40% of all adults are living with nonalcoholic fatty liver disease (NAFLD). In Europe, 20–30% of the
0 Comments
Jul 31 2019 MR Solutions has received the prestigious Queen’s Award for Enterprise in recognition of the company’s innovative PET imaging technology for use in pre-clinical research. MR Solutions already holds Queens Awards for innovation in 2016 and for export achievement in 2017. MR Solutions has been the world leader in new developments in pre-clinical
0 Comments
The findings of a new study suggest that people who receive highly personalized combination therapy for treatment-resistant cancer can experience improved disease control and survival rates. Can highly personalized precision medicine bring more benefits to people with metastatic cancer? Recently, precision medicine has been gaining ground as a potentially more effective approach to treating a
0 Comments
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) today announced formation of the Pelotonia Institute for Immuno-Oncology (PIIO), a comprehensive bench-to-bedside research initiative focused on harnessing the body’s immune system to fight cancer at all levels-;from prevention to treatment and survivorship.
0 Comments
Medical device OEMs in search of commercialization and manufacturing solutions for lateral flow immunization (LFI) and medical diagnostic devices will discover several new capabilities and services that virtually eliminate product variability, improve overall quality and lower costs from contract manufacturer (CMO) Web Industries at AACC 2019, August 4 – 8, Anaheim Convention Center. At the
0 Comments
A new drug for treating Alzheimer’s disease has successfully passed the first phase of testing in humans. Preclinical studies had already shown that the drug could improve memory and other symptoms of Alzheimer’s disease in older mice. A potential treatment for Alzheimer’s moves a step closer. Researchers at Forschungszentrum Jülich and Heinrich Heine University Düsseldorf,
0 Comments